Canadian Institutes of Health Research Institute of Neurosciences, Mental Health and Addiction

Canadian Institutes of Health Research Institute of Neurosciences, Mental Health and Addiction
Name	Institute of Neurosciences, Mental Health and Addiction
Formed	2000s
Jurisdiction	Canada
Headquarters	Ottawa
Parent department	Canadian Institutes of Health Research

Canadian Institutes of Health Research Institute of Neurosciences, Mental Health and Addiction is a virtual institute within the Canadian Institutes of Health Research system that supports research on neurological disorders, psychiatric conditions, and substance use. It funds and coordinates research across Canadian universities and research hospitals while engaging with international partners and stakeholders in neuroscience, psychiatry, and addiction science. The institute aligns with national health priorities and translational objectives to improve diagnosis, treatment, and policy responses.

Overview and mandate

The institute's mandate emphasizes discovery and translation across neurology, psychiatry, and addiction medicine by supporting basic, clinical, and population health research in collaboration with stakeholders such as the Royal College of Physicians and Surgeons of Canada, Health Canada, and the Public Health Agency of Canada. It aims to accelerate research from laboratories like those at the Montreal Neurological Institute–Hospital and the Hospital for Sick Children toward applications relevant to institutions including the Canadian Institutes of Health Research, CIHR Institute of Aging, and provincial health research funders such as Ontario Research Fund and Quebec’s Fonds de recherche du Québec. The mandate intersects with professional bodies such as the Canadian Psychiatric Association, research networks including the Canadian Network for Mood and Anxiety Treatments, and international entities like the National Institutes of Health and the European Commission.

Research priorities and programs

Priority areas include neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease), mood disorders (e.g., major depressive disorder, bipolar disorder), psychotic disorders (e.g., schizophrenia), developmental conditions (e.g., autism spectrum disorder), and substance use disorders (e.g., opioid crisis, alcohol use disorder). Programs support bench science at facilities such as the Hotchkiss Brain Institute and Douglas Research Centre, translational trials at centres like Sunnybrook Health Sciences Centre and Vancouver General Hospital, and population research at universities such as the University of British Columbia, McGill University, University of Toronto, and McMaster University. Cross-cutting initiatives focus on precision medicine exemplified by collaborations with the Canadian Open Neuroscience Platform, data harmonization consistent with the Global Alliance for Genomics and Health, and mental health services research with partners such as the Centre for Addiction and Mental Health.

Funding and grant mechanisms

The institute distributes funds through CIHR mechanisms including open operating grants, strategic operating grants, and priority-driven funding competitions, coordinating with programs like the Canada Foundation for Innovation and the Canadian Institutes of Health Research's Project Grant. Grant mechanisms often complement awards from bodies such as the Canadian Institutes for Advanced Research, the Canadian Cancer Society, and the Michael Smith Foundation for Health Research. Funding schemes support trainees via mechanisms akin to the Natural Sciences and Engineering Research Council of Canada scholarships and clinical investigator awards similar to the Canadian Institutes of Health Research Fellowship. Large consortia funding has paralleled international programs such as the Human Brain Project and national initiatives like the Canadian Brain Research Strategy.

Organizational structure and leadership

The institute operates within CIHR’s virtual institute model, reporting to CIHR Governing Council members and coordinating with scientific directors, advisory boards, and working groups comprising experts from institutions like Queen's University, Dalhousie University, University of Calgary, and University of Alberta. Leadership roles bring together clinicians and researchers connected to organizations such as the Canadian Academy of Health Sciences, the Canadian Association of Neuroscience, and specialty societies like the American Psychiatric Association and the Society for Neuroscience. Advisory panels include representatives from patient advocacy groups such as the Schizophrenia Society of Canada, the Alzheimer Society of Canada, and the Canadian Mental Health Association.

Partnerships and collaborations

The institute partners with provincial research bodies like the Alberta Innovates, national charities such as the Brain Canada Foundation and the Canadian Institutes for Health Research Foundation, and international funders including the National Institute of Mental Health and the Wellcome Trust. Collaborative networks include disease-specific consortia such as the Canadian ALS Research Consortium, the Canadian Consortium on Neurodegeneration in Aging, and global collaborations with initiatives like the International League Against Epilepsy and the World Health Organization. It also engages industry partners including pharmaceutical companies active at research hospitals like the BC Children's Hospital Research Institute and technology collaborations with entities engaged in data standards like the Observational Health Data Sciences and Informatics community.

Impact, initiatives, and notable projects

Notable projects facilitated or funded by the institute include large-scale cohort studies, multi-centre clinical trials, and knowledge-translation initiatives in partnership with the Canadian Task Force on Preventive Health Care, the Canadian Agency for Drugs and Technologies in Health, and provincial health ministries such as Ontario Ministry of Health. Impact areas include contributions to research on traumatic brain injury at centres like The Ottawa Hospital, advances in neuroimaging using platforms developed at the Rotman Research Institute, progress in genomics tied to the Canadian Genomics Network, and implementation science partnerships with the Institute for Clinical Evaluative Sciences. The institute’s efforts have supported training pipelines affiliated with the Canadian Resident Matching Service and specialty certification pathways recognized by the Royal College of Physicians and Surgeons of Canada, while influencing policy discussions involving parliamentary committees and stakeholders such as the Canadian Medical Association.

Category:Health research in Canada